31358793|t|Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer's disease.
31358793|a|Lipid metabolism is abnormal in Alzheimer's disease (AD) brain leading to ceramide and sphingosine accumulation and reduced levels of brain sphingosine-1-phosphate (S1P). We hypothesize that changes in S1P signaling are central to the inflammatory and immune-pathogenesis of AD and the therapeutic benefits of fingolimod, a structural analog of sphingosine that is FDA approved for the treatment of multiple sclerosis. We recently reported that the neuroprotective effects of fingolimod in 5xFAD transgenic AD mice treated from 1-3 months of age were greater at 1 mg/kg/day than at 5 mg/kg/day. Here we performed a dose-response study using fingolimod from 0.03 to 1 mg/kg/day in 5xFAD mice treated from 1-8 months of age. At 1 mg/kg/day, fingolimod decreased both peripheral blood lymphocyte counts and brain Abeta levels, but at the lowest dose tested (0.03 mg/kg/day), we detected improved memory, decreased activation of brain microglia and astrocytes, and restored hippocampal levels of GABA and glycerophosphocholine with no effect on circulating lymphocyte counts. These findings suggests that, unlike the case in multiple sclerosis, fingolimod may potentially have therapeutic benefits in AD at low doses that do not affect peripheral lymphocyte function.
31358793	31	41	fingolimod	Chemical	MESH:D000068876
31358793	47	52	mouse	Species	10090
31358793	62	81	Alzheimer's disease	Disease	MESH:D000544
31358793	83	88	Lipid	Chemical	MESH:D008055
31358793	115	134	Alzheimer's disease	Disease	MESH:D000544
31358793	136	138	AD	Disease	MESH:D000544
31358793	157	165	ceramide	Chemical	MESH:D002518
31358793	170	181	sphingosine	Chemical	MESH:D013110
31358793	223	246	sphingosine-1-phosphate	Chemical	MESH:C060506
31358793	248	251	S1P	Chemical	MESH:C060506
31358793	285	288	S1P	Chemical	MESH:C060506
31358793	318	330	inflammatory	Disease	MESH:D007249
31358793	358	360	AD	Disease	MESH:D000544
31358793	393	403	fingolimod	Chemical	MESH:D000068876
31358793	428	439	sphingosine	Chemical	MESH:D013110
31358793	482	500	multiple sclerosis	Disease	MESH:D009103
31358793	559	569	fingolimod	Chemical	MESH:D000068876
31358793	590	592	AD	Disease	MESH:D000544
31358793	593	597	mice	Species	10090
31358793	724	734	fingolimod	Chemical	MESH:D000068876
31358793	769	773	mice	Species	10090
31358793	822	832	fingolimod	Chemical	MESH:D000068876
31358793	893	898	Abeta	Gene	14961
31358793	1075	1079	GABA	Chemical	MESH:D005680
31358793	1084	1105	glycerophosphocholine	Chemical	MESH:D005997
31358793	1204	1222	multiple sclerosis	Disease	MESH:D009103
31358793	1224	1234	fingolimod	Chemical	MESH:D000068876
31358793	1280	1282	AD	Disease	MESH:D000544
31358793	Negative_Correlation	MESH:C060506	MESH:D008055
31358793	Association	MESH:D008055	MESH:D000544
31358793	Positive_Correlation	MESH:D008055	MESH:D013110
31358793	Positive_Correlation	MESH:D013110	MESH:D000544
31358793	Association	MESH:D002518	MESH:D008055
31358793	Negative_Correlation	MESH:D013110	MESH:D009103
31358793	Positive_Correlation	MESH:D000068876	MESH:D005680
31358793	Positive_Correlation	MESH:D002518	MESH:D000544
31358793	Negative_Correlation	MESH:D000068876	MESH:D000544
31358793	Positive_Correlation	MESH:D000068876	MESH:D005997
31358793	Association	MESH:C060506	MESH:D000068876
31358793	Negative_Correlation	MESH:D000068876	MESH:D009103
31358793	Association	MESH:C060506	MESH:D007249
31358793	Negative_Correlation	MESH:C060506	MESH:D000544
31358793	Negative_Correlation	MESH:D000068876	14961

